Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK-alpha1), encoded by the PRKAA1 gene, is the primary catalytic component of the heterotrimeric AMPK complex, which acts as a master energy sensor in eukaryotic cells. In response to metabolic stress that elevates the cellular AMP/ATP ratio, AMPK-alpha1 is activated via phosphorylation at Thr172 by upstream kinases such as LKB1 and CaMKKbeta. Once active, it orchestrates a shift from energy-consuming anabolic pathways (such as lipid, protein, and glycogen synthesis) to energy-producing catabolic pathways (such as fatty acid oxidation, glucose uptake, and autophagy) to restore cellular energy homeostasis.
AMPK-alpha1 plays a critical role in several human pathologies, making it a highly attractive therapeutic target. In metabolic disorders like type 2 diabetes and obesity, its activation improves insulin sensitivity and glucose disposal. In cardiovascular diseases, it offers cardioprotection during ischemia-reperfusion injury, though chronic overactivation can lead to adverse cardiac remodeling, hypertrophy, and glycogen accumulation. In oncology, AMPK-alpha1 exhibits a dual, context-dependent role: it acts as a tumor suppressor in early-stage cancers by inhibiting mTORC1 and cell proliferation, but can promote the survival of established tumor cells under hypoxic or nutrient-deprived conditions. Pharmacological modulators of AMPK-alpha1 include indirect activators like metformin and phenformin, as well as direct small-molecule activators such as AICAR, A-769662, and MK-8722, which are being actively researched to optimize tissue-specific and isoform-selective targeting.
Direct or indirect activation of the catalytic subunit of AMP-activated protein kinase (AMPK), leading to phosphorylation of downstream metabolic enzymes and transcription factors to restore cellular energy balance.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK-alpha1).